Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG: 3613)

Market Cap	6.19B
Revenue (ttm)	1.38B
Net Income (ttm)	494.14M
Shares Out	837.10M
EPS (ttm)	0.59
PE Ratio	12.52
Forward PE	9.79
Dividend	0.33 (4.40%)
Ex-Dividend Date	Jun 12, 2024

Volume	1,268,000
Open	7.53
Previous Close	7.50
Day's Range	7.25 - 7.53
52-Week Range	7.18 - 13.84
Beta	0.41
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Beijing Tong Ren Tang Chinese Medicine Company

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates retail outlets in Hong Kong and in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1669
• Employees: 798
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3613

Financial Performance

In 2023, Beijing Tong Ren Tang Chinese Medicine Company's revenue was 1.52 billion, a decrease of -11.91% compared to the previous year's 1.73 billion. Earnings were 540.39 million, a decrease of -16.33%.